Keith S Manchester is of Roivant Sciences Ltd.. Currently has a direct ownership of 1.28 Million shares of ROIV, which is worth approximately $15.3 Million. The most recent transaction as insider was on Sep 25, 2024, when has been sold 134,948 shares (Common Shares) at a price of $11.77 per share, resulting in proceeds of $1,588,337. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.28M
0% 3M change
1725.4% 12M change
Total Value Held $15.3 Million

KEITH S MANCHESTER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 25 2024
SELL
Open market or private sale
$1,588,337 $11.77 p/Share
134,948 Reduced 9.56%
1,277,178 Common Shares
Sep 24 2024
SELL
Open market or private sale
$4,276,764 $11.62 p/Share
368,052 Reduced 20.68%
1,412,126 Common Shares
Sep 10 2024
BUY
Grant, award, or other acquisition
-
16,406 Added 0.91%
1,780,178 Common Shares
Sep 12 2023
BUY
Grant, award, or other acquisition
-
17,825 Added 20.3%
69,967 Common Shares
Sep 15 2022
BUY
Grant, award, or other acquisition
-
52,142 Added 50.0%
52,142 Common Shares

Also insider at

ABUS
Arbutus Biopharma Corp Healthcare
KSM

Keith S Manchester

London, X0

Track Institutional and Insider Activities on ROIV

Follow Roivant Sciences Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ROIV shares.

Notify only if

Insider Trading

Get notified when an Roivant Sciences Ltd. insider buys or sells ROIV shares.

Notify only if

News

Receive news related to Roivant Sciences Ltd.

Track Activities on ROIV